Communicating epidemiology study results to subjects, affected workers, and community members is an important part of compliance and alignment with our company's policies, industry's Responsible Care® Principles, and the doctrines of Good Epidemiology Practices. It is the responsibility of the investigators to interpret their research appropriately for each audience, and to assure that all who have a need or right to know get information in a form meaningful to them. We discuss study communication with examples from a recent evaluation of communication efforts within Dow and our experience with occupational and community studies on dioxin. We also discuss how we currently structure worker and community communication based on this experience. Since each Dow protocol must include a communication plan, when we agree to undertake a study, we are also agreeing to communicate study results. Depending upon the nature and type of the study, there may also be some prestudy communication. We encourage all investigators to share the results of their studies more broadly than just scientific publication and plan for the study communication before the study is initiated.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Environmental Health Open Access 04 May 2010
Subscribe to Journal
Get full journal access for 1 year
only $19.83 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Acquavella J.F., and Collins J.J. Perspective on the content of worker notifications. Am J Ind Med 1993: 23: 77–83.
Bayer R. Notifying workers at risk: the politics of the right to know. Am J Pub Health 1986: 76: 1352–1356.
Bender A.P., Williams A.N., and Parker D.L. Experiences of a state-sponsored notification and screening program for asbestos workers. Am J Ind Med 1993: 23: 161–169.
Bodner K., et al. Cancer risk for chemical workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Occup Environ Med 2003: 60: 672–675.
Bond G.G. Dioxin: a case study. Am J Ind Med 1993: 23: 177–182.
Chemical Manufacturers Association's Epidemiology Task Group. Guidelines for good epidemiology practices for occupational and environmental epidemiological research. J Occup Med 1991: 33: 1221–1229.
Collins J.J., et al. A framework for addressing health issues in or near a manufacturing facility. J Occup Environ Med 2000: 42: 163–170.
Collins J.J., and Conner P.R. Communication to workers of epidemiology study results: an industry approach. J Occup Med 1994: 36: 169–173.
Cook R.R. Dioxin, chloracne, and soft tissue sarcoma. Lancet 1981: 1: 618–619.
Cook R.R. Soft tissue sarcomas: clues and caution. In: Human and Environmental Risks of Chlorinated Dioxins and Related Compounds, Tucker R.B., Young A.L., and Gray A.B. (eds). Plenum Publishing Corporation, New York, 1983.
Cook R.R., and Cartmill J.B. Dioxin: comparing apples and oranges. Chemtech 1984a: 14: 534–537.
Cook R.R., and Cartmill J.B. Soft tissue sarcoma and dioxins: putting the data into perspective. Public Health Risks of the Dioxins Proceedings. William Kaufmann, Los Altos, CA, 1984b, pp. 205–216.
Cook R.R., et al. Mortality experience of employees exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). J Occup Med 1980: 22(8): 530–532.
Covello V.T. Risk communication and occupational medicine. J Occup Med 1993: 35: 18–19.
Doll R., and Peto R. The Causes of Cancer: Quantitative Estimates of Avoidable Risk of Cancer in the United States Today. Oxford University Press: New York, 1981.
Fingerhut M.A., Halperin W.E., Honchar P.A., Smith A.B., Groth D.H., and Russell W.O. Review of exposure and pathology data for seven cases reported as soft tissue sarcoma among persons occupationally exposed to dioxin-contaminated herbicides. Public Health Risks of the Dioxins, Proceedings of a Symposium held 19–20 October, 1983, Rockefeller University, New York. William Kaufmann, Los Altos, CA, 1984, pp. 187–203.
Fingerhut M.A., et al. Cancer mortality in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. N Engl J Med 1991: 324(4): 212–218.
Marsh G.W., et al. Drake Chemical Workers' Health Registry: Notification and medical surveillance of a group of workers at high risk of developing bladder cancer. Am J Ind Med 1991: 19: 291–301.
Michigan Department of Public Health. Evaluation of soft and connective tissue cancer mortality rates for midland and other selected Michigan counties compared nationally and statewide, Michigan Department of Public Health, Lansing, MI, 1983.
Ott M.G., et al. Linking industrial hygiene and health records. Am Ind Hyg Assoc J 1975: 36: 760–766.
Riggan, et al. Environmental Protection Agency. U.S. Cancer Mortality Rates and Trends, 1950–1979. US Government Printing Office, Washington, 1984.
Rosenman K.D., et al. High-risk notification of chromate and bichromate production worker. Am J Ind Med 1993: 23: 125–134.
Schulte P.A., et al. Notification of a cohort of workers at risk of bladder cancer. J Occup Med 1985: 27(1): 19–28.
Sparks P.J., and Cooper M. Risk characterization, risk communication, and risk management. J Occup Med 1993: 35: 13–17.
Steenland K., et al. Cancer, heart disease, and diabetes in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Natl Cancer Inst 1999: 91(9): 779–786.
Tillett S., et al. Interventions in high-risk occupational cohorts: a cross-sectional demonstration project. J Occup Med 1986: 28: 719–727.
The Dow Chemical Company supported this work.
About this article
Cite this article
Collins, J., Bodner, K., Baase, C. et al. Communication of epidemiology study results by industry: The Dow Chemical Company approach. J Expo Sci Environ Epidemiol 14, 492–497 (2004). https://doi.org/10.1038/sj.jea.7500394
- right to know
- soft-tissue sarcoma
This article is cited by
Environmental Health (2010)